NewslettersMesenchymal Cell NewsDexamethasone-Integrated Mesenchymal Stem Cells for Systemic Lupus Erythematosus Treatment via Multiple Immunomodulatory MechanismsBy Noshin Noorjahan - May 9, 2024062Scientists presented a promising strategy based on dexamethasone liposome-integrated MSCs for treating systemic lupus erythematosus via multiple immunomodulatory pathways.[ACS Nano]AbstractGraphical Abstract